Business Context and Reporting Period
This Form 6-K filing by Therapix Biosciences Ltd. (not Scisparc Ltd.) is dated October 14, 2020. The report announces a change in the format of the Company's Special General Meeting of Shareholders due to COVID-19 regulations in Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and contains no financial statements or performance data.
Material Changes
The primary material change is the conversion of the Special General Meeting of Shareholders from a physical gathering to a virtual event via Zoom videoconference. The meeting is scheduled for October 16, 2020, at 8:00 a.m. Eastern Time.
Guidance, Outlook, and Risks
Management commentary is limited to the logistical details of the virtual meeting. Shareholders must register by emailing the Chief Financial Officer, Mr. Oz Adler, by 7:00 a.m. Eastern Time on the day of the meeting to receive the Zoom link. No financial guidance, outlook, or specific risk factors beyond the general context of the pandemic are disclosed in this text.
Key Facts for Investor Verification
- The Special General Meeting will be held virtually on October 16, 2020.
- Shareholders must register via email to oz@therapixbio.com by 7:00 a.m. Eastern Time on the meeting date to attend.
- This filing incorporates by reference into the Company's registration statements on Form F-3 and Form S-8.
- No financial performance data is included in this specific report.